DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Otilonium bromide

Otilonium bromide

  • Isopropamide Iodide

    Isopropamide Iodide

  • The National Drugs List

    The National Drugs List

  • WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No

    WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No

  • Muscarinic Acetylcholine Receptor

    Muscarinic Acetylcholine Receptor

  • The Role of Antispasmodics in Managing Irritable Bowel Syndrome

    The Role of Antispasmodics in Managing Irritable Bowel Syndrome

  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Drug

    NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Drug

  • A Four-Country Comparison of Healthcare Systems, Implementation

    A Four-Country Comparison of Healthcare Systems, Implementation

  • TITLE: Trimebutine Maleate and Pinaverium Bromide for Irritable Bowel Syndrome: a Review of the Clinical Effectiveness, Safety and Guidelines

    TITLE: Trimebutine Maleate and Pinaverium Bromide for Irritable Bowel Syndrome: a Review of the Clinical Effectiveness, Safety and Guidelines

  • Government Gazette

    Government Gazette

  • Antiallergics Loratadinep Allergy √ JP DMF Antiarrhythmics

    Antiallergics Loratadinep Allergy √ JP DMF Antiarrhythmics

  • (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

    (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

  • Surveillance Review Proposal PDF 387 KB

    Surveillance Review Proposal PDF 387 KB

  • Effect of Herbal Extract Granules Combined with Otilonium Bromide on Irritable Bowel Syndrome with Diarrhoea: a Study Protocol for a Randomised Controlled Trial

    Effect of Herbal Extract Granules Combined with Otilonium Bromide on Irritable Bowel Syndrome with Diarrhoea: a Study Protocol for a Randomised Controlled Trial

  • 2015.09 IBS Drug Class Review.Pdf

    2015.09 IBS Drug Class Review.Pdf

  • Irritable Bowel Syndrome

    Irritable Bowel Syndrome

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Current Pharmacologic Treatments of Irritable Bowel Syndrome

    Current Pharmacologic Treatments of Irritable Bowel Syndrome

  • Is Otilonium Bromide Really Effective for Treating Asian Patients with Irritable Bowel Syndrome?: Author’S Reply

    Is Otilonium Bromide Really Effective for Treating Asian Patients with Irritable Bowel Syndrome?: Author’S Reply

Top View
  • Effect of Antispasmodic Agents for the Treatment of Irritable Bowel Syndrome
  • Development and Validation of Analytical Methods for the Determination of Some Drugs Used for the Treatment of Colon Diseases
  • Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)
  • Understanding Bloating and Distension
  • HA Standard Drug Formulary (Drug List) 050218
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Irritable Bowel Syndrome. Relevance of Antispasmodics
  • Customs Tariff - Schedule
  • DOWNLOAD INKE Apis PRODUCT LIST
  • Pharmaabkommen A1 E
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • Management of Irritable Bowel Syndrome (Ibs) in Children
  • Otilonium and Pinaverium Trigger Mitochondrial-Mediated Apoptosis in Rat Embryo Cortical Neurons in Vitro T
  • Muscarinic Acetylcholine Receptor
  • Customs Tariff - Schedule Xxi - 1
  • IBS-Monograph-2018.Pdf


© 2024 Docslib.org    Feedback